Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.

The glucose-lowering effect within 1 h (ΔPG av,0–1h ) for faster aspart was in line with the findings for the primary endpoint, but did not reach statistical significance; however, PG concentration values for faster aspart were statistically significantly lower after 1 h (PG 1h ) compared with IAsp ( Table 2 ).

also in 111,027 other papers